Literature DB >> 8940360

A midregion parathyroid hormone-related peptide mobilizes cytosolic calcium and stimulates formation of inositol trisphosphate in a squamous carcinoma cell line.

J J Orloff1, M B Ganz, M H Nathanson, M S Moyer, Y Kats, M Mitnick, A Behal, J Gasalla-Herraiz, C M Isales.   

Abstract

A midregion fragment of PTH-related protein (PTHrP), which is intensively conserved across species, has been identified as a secretory product of several different cell types, including keratinocytes and squamous carcinomas. As recent data suggest that a midregion PTHrP fragment may be biologically active, we hypothesized that midregion PTHrPs interact with unique cell surface receptors that mediate autocrine or paracrine action. Dose-dependent transient elevations in intracellular calcium ([Ca2-]i) were observed in fura-2-loaded SqCC/Y1 squamous carcinoma cells exposed to human (h) PTHrP-(67-86)NH2, [Tyr36]hPTHrP-(1-36)NH2, and hPTHrP-(1-141) at concentrations ranging from 1 pM to 1 microM. The effects of maximal stimulatory concentrations of [Tyr36]PTHrP-(1-36)NH2 and PTHrP-(67-86)NH2 on [Ca2+]i were additive. The inhibitory PTH analog, [D-Trp12,Tyr34]bovine PTH-(7-34)NH2, attenuated the [Ca2+]i response to [Tyr36]hPTHrP-(1-36)NH2, but not that to PTHrP-(67-86)NH2. These data suggest that PTHrP-(67-86)NH2 activates a different receptor pathway in SqCC/Y1 cells from the one activated by [Tyr36]hPTHrP-(1-36)NH2. Radiolabeled PTHrP-(67-86)NH2 did not bind to SqCC/Y1 cells, and PTHrP-(67-86)NH2 did not compete for binding of 125I-labeled [Tyr36]PTHrP-(1-36)NH2 to PTH/PTHrP receptors on SaOS-2 osteosarcoma cells. Activation of the phospholipase C pathway by PTHrP-(67-86)NH2 was confirmed by exposing SqCC/Y1 cells to peptide for 1 min and measuring the accumulation of inositol trisphosphates. PTHrP-(67-86)NH2 treatment (100 nM) resulted in maximal stimulation of inositol trisphosphates of 3.1 +/- 0.1-fold over the control value, with an EC50 of 1.5 +/- 1.2 nm. In contrast, PTHrP-(67-86)NH2 (0.1 nM to 1 microM) did not stimulate adenylyl cyclase in SqCC/Y1 cells despite vigorous stimulation of cAMP formation by isoproterenol (1 microM) to 66-fold over the basal value. To determine whether messenger RNA (mRNA) prepared from SqCC/Y1 cells would direct the translation of a receptor protein that mediated a [Ca2+]i response to PTHrP-(67-86)NH2, we performed expression studies in Xenopus oocytes. Fluo-3 fluorescence in Xenopus oocytes expressing SqCC/Y1 mRNA was visualized by confocal video microscopy after exposure to 1 microM PTHrP-(67-86)NH2. Clear increases in [Ca2+]i were detected in mRNA-injected, but not in sham-injected, oocytes. Finally, we examined the effect of PTHrP-(67-86)NH2 treatment on fibronectin secretion from SqCC/YN1 cells. A significant 3.5-fold increase in fibronectin secretion into conditioned medium was observed when SqCC/Y1 cells were exposed to 100 nM PTHrP-(67-86)NH2, and this effect was dose dependent, with an EC50 of 0.1 nM. We conclude that PTHrP-(67-86)NH2 activates phospholipase C-dependent pathways in SqCC/Y1 cells through a receptor distinct from that activated by PTHrP-(1-36) in the same cells. As a midregion secretory fragment of PTHrP has been partially purified from several different cell types, this receptor may have broad biological significance.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8940360     DOI: 10.1210/endo.137.12.8940360

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

1.  Lung carcinoma progression and survival versus amino- and carboxyl-parathyroid hormone-related protein expression.

Authors:  Randolph H Hastings; Philippe R Montgrain; Rick A Quintana; Boris Chobrutskiy; Ashkhan Davani; Atsushi Miyanohara; Sepi Mahooti
Journal:  J Cancer Res Clin Oncol       Date:  2017-03-25       Impact factor: 4.553

2.  The midregion, nuclear localization sequence, and C terminus of PTHrP regulate skeletal development, hematopoiesis, and survival in mice.

Authors:  Ramiro E Toribio; Holly A Brown; Chad M Novince; Brandlyn Marlow; Krista Hernon; Lisa G Lanigan; Blake E Hildreth; Jillian L Werbeck; Sherry T Shu; Gwendolen Lorch; Michelle Carlton; John Foley; Prosper Boyaka; Laurie K McCauley; Thomas J Rosol
Journal:  FASEB J       Date:  2010-02-09       Impact factor: 5.191

3.  Ablation of the PTHrP gene or the PTH/PTHrP receptor gene leads to distinct abnormalities in bone development.

Authors:  B Lanske; M Amling; L Neff; J Guiducci; R Baron; H M Kronenberg
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

Review 4.  Twenty-five years of PTHrP progress: from cancer hormone to multifunctional cytokine.

Authors:  Laurie K McCauley; T John Martin
Journal:  J Bone Miner Res       Date:  2012-05-01       Impact factor: 6.741

5.  Duplicated zebrafish co-orthologs of parathyroid hormone-related peptide (PTHrP, Pthlh) play different roles in craniofacial skeletogenesis.

Authors:  Yi-Lin Yan; Poulomi Bhattacharya; Xin Jun He; Bhaskar Ponugoti; Ben Marquardt; Jason Layman; Melissa Grunloh; John H Postlethwait; David A Rubin
Journal:  J Endocrinol       Date:  2012-07-03       Impact factor: 4.286

6.  Opposing mitogenic and anti-mitogenic actions of parathyroid hormone-related protein in vascular smooth muscle cells: a critical role for nuclear targeting.

Authors:  T Massfelder; P Dann; T L Wu; R Vasavada; J J Helwig; A F Stewart
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

7.  The N- and C-terminal domains of parathyroid hormone-related protein affect differently the osteogenic and adipogenic potential of human mesenchymal stem cells.

Authors:  Antonio Casado-Diaz; Raquel Santiago-Mora; José Manuel Quesada
Journal:  Exp Mol Med       Date:  2010-02-28       Impact factor: 8.718

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.